Kevin Lye

Kevin Lye, MD, MBA, currently serves as a Medical Advisor at Accorto Regulatory Solutions starting in November 2023. Lye has been a Partner at GUILD Consulting since January 2019 and has held multiple Chief Medical Officer roles at iFirst Medical Technologies, YGEIA Group, and Colorado Therapeutics LLC from October 2016 to June 2023, among others. Lye’s previous experience also includes serving as VP of Medical Affairs at Northwest Biotherapeutics and as VP and Chief Medical Officer at Pono Pharma. Lye completed a Doctor of Medicine degree at Wake Forest University School of Medicine and holds an MBA from Hawaii Pacific University. Lye has multiple Bachelor of Science and Bachelor of Arts degrees in Mathematics, Biochemistry, Chemistry, and Biology from North Carolina State University.